Skip to main content
Log in

Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacin

  • New Antimicrobial Agents
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

Five fluoroquinolones were tested against 300 staphylococci from a wide variety of US medical centers including 150 strains resistant to penicil-linase-resistant penicillins (PRP-resistant). Ten ciprofloxacin-resistant strains of PRP-resistantStaphylococcus aureus were relatively resistant to the other fluoroquinolones, but the remaining 290 isolates were susceptible to all five drugs at established or anticipated breakpoint concentrations. The relative potency of the study drugs could be ranked as follows: CI-960>PD 131628>sparfloxacin > ciprofloxacin > ofloxacin. All five drugs were bactericidal against PRP-resistant and PRP-susceptible staphylococci.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Barry AL, Jones RN In vitro activity of ciprofloxacin against gram-positive cocci. American Journal of Medicine 1986, 82: 27–32.

    Google Scholar 

  2. Daum TE, Schaberg DR, Terpenning MS, Sottile WS, Kauffman CA Increasing resistance ofStaphylococcus aureus to ciprofloxacin. Antimicrobial Agents and Chemotherapy 1990, 34: 1862–1863.

    PubMed  Google Scholar 

  3. Raviglione MC, Boyle JF, Mariuz P, Pablos-Mendez A, Cotes H, Merlo A Ciprofloxacin-resistant methicillin-resistantStaphylococcus aureus in an acute-care hospital. Antimicrobial Agents and Chemotherapy 1990, 34: 2050–2054.

    PubMed  Google Scholar 

  4. Kojima T, Inoue M, Mitsuhashi S In vitro activity of AT-4140 against quinolone- and methicillin-resistantStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1990, 34: 1123–1127.

    PubMed  Google Scholar 

  5. Chaudhry AZ, Knapp CC, Sierra-Madero J, Washington JA Antistaphylococcal activities of sparfloxacin (CI-978, AT-4140), ofloxacin, and ciprofloxacin. Antimicrobial Agents and Chemotherapy 1990, 34: 1843–1845.

    PubMed  Google Scholar 

  6. Cohen MA, Huband MD, Mailloux GB, Yoder SL, Roland GE, Domagala JM, Heifetz CL In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine antiinfective. Antimicrobial Agents and Chemotherapy 1991, 35: 141–146.

    PubMed  Google Scholar 

  7. Norby SR, Jonsson M Comparative in vitro activity of PD 127391, a new fluorinated 4-quinolone derivative. Antimicrobial Agents and Chemotherapy 1988, 32: 1278–1281.

    PubMed  Google Scholar 

  8. Jones RN, Barry AL, Gardiner RV, Packer RR The prevalence of staphylococcal resistance to penicillinase-resistant penicillins, a retrospective and prospective national surveillance trial of isolates from 40 medical centers. Diagnostic Microbiology and Infectious Disease 1989, 12: 385–394.

    PubMed  Google Scholar 

  9. National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed. Approved standard M7-A2. NCCLS, Villanova, PA, 1990.

    Google Scholar 

  10. Pearson RD, Steigbigel RT, Davis HT, Chapman SW Method for reliable determination of minimal lethal antibiotic concentrations. Antimicrobial Agents and Chemotherapy 1980, 19: 699–708.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barry, A.L., Fuchs, P.C. Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacin. Eur. J. Clin. Microbiol. Infect. Dis. 10, 168–171 (1991). https://doi.org/10.1007/BF01964451

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01964451

Keywords

Navigation